Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis

This publication has 36 references indexed in Scilit:

• Impact of epoetin‐β on survival of patients with lymphoproliferative malignancies: long‐term follow up of a large randomized study*
  British Journal of Haematology, 2005
• The Erythropoietin Receptor and Its Expression in Tumor Cells and Other Tissues
  The Oncologist, 2004
• Erythropoietin for patients with malignant disease
  Published by Wiley ,2004
• Erythropoietin to treat anaemia in patients with head and neck cancer
  The Lancet, 2004
• Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
  The Lancet, 2003
• Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies
  Journal of Clinical Oncology, 2002
• Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study
  European Journal Of Cancer, 2001
• Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy
  Medical Oncology, 1998
• Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO)
  European Journal Of Cancer, 1998
• Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma
  British Journal of Surgery, 1998